BACKGROUND: Small cell lung cancer (SCLC) accounts for 10-15% of all lung malignancies and its prognosis is dismal. Although early studies have shown promising clinical activity of immune checkpoint blockers, the immune composition and expression of potentially actionable immunostimulatory targets i...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!